Andy is the lead pharmacist for oncology at the Mid Yorkshire Hospitals NHS Trust. He has an interest improving early diagnosis rates in patients who present outside of formal screening programmes, and is engaged in research regarding the potential of community pharmacy to identify opportunistic presentations of disease. He is involved in an ongoing collaboration project between the British Oncology Pharmacy Association (BOPA) and HEE in this field.